Ceftriaxone versus chloramphenicol for treatment of acute typhoid fever

Life Science Journal

Volumn 8, Issue 2, 2011, Pages 100-105

  Hammad, Osama Mohamed ^a   Hifnawy, Tamer ^a   Omran, Dalia ^b   El Tantawi, Magda Anwar ^c   Girgis, Nabil Isaknder ^d  

^a BENI SUEF UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c Bacteriology Department   (Egypt)

^d NAMRU3   (Egypt)

Author keywords

Ceftriaxone; Chloramphenicol; Multidrug resistance; Typhoid fever

Indexed keywords

SALMONELLA TYPHI;

EID: 79957672971     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cooke F, Wain J. The emergence of antibiotic resistance in typhoid fever. Travel Med Infec Dis. 2004; 2 (2): 67-74.
2. Wasfy M, Frenck R, Ismail T, Mansour H, Malone J. and Mahoney F. Trends of multiple drug resistance among Salmonella serotype typhi isolates during a 14 year period in Egypt. Clin Infect Dis. 2002; 35 (10): 1265-8.
3. Sippel JE, Diab AS, Mikhail AI. Chloramphenicol resistant Salmonella typhi in Egypt. Trans R Soc Trop Med Hyg. 1981; 75: 613.
4. Mourad AS, Metwally M, el Deen AN, Threlfall EJ, Rowe B, Mapes T, et al. Multiple drug resistant Salmonella typhi. Clin Infect Dis. 1993; 17: 135-6.
5. Wasfy MO, Moustafa DA, El-Gendy AM, Mohran ZS, Ismail TF, El-Etr SH, et al. Prevalence of antibiotic resistance among Egyptian Salmonella typhi strains. J Egypt Public Health Assoc. 1996; LXXI: 149-60.
6. Capoor MR, Nair D, Hasan AS, Aggarwal P, Gupta B. Typhoid fever: narrowing therapeutic options in India. Southeast Asian. J Trop Med Public Health. 2006;37 (6): 1170-4.
7. Dimitrov T, Udo EE, Albaksami O, Kilani AA, Shehab el-DM. Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype paratyphi A with reduced susceptibility to ciprofloxacin. J Med Microbiol. 2007; 56 (pt. 2): 277-9.
8. Kumar R, Gupta N, Shalini N. Multidrug-resistant typhoid fever. Indian J Pediatr. 2007; 74(1):39-42
9. Ohashi M. In: Balows, A.; Hausler, W.; Lennette, E. (eds). Laboratory diagnosis of infectious disease: principles and practice. 1988;Vol. I. Springer Verlag; 525-32.
10. House D, Wain J, Ho VA, Diep TS, Chinh NT, Bay PV, et al. Serology of typhoid fever in an area of endemicity and its relevance to diagnosis. Journal of ClinicalMicrobiology. 2007;39(3):1002-1007
11. Esser VM, Elefson DE. Experiences with the Kirby-Bauer method of antibiotic susceptibility testing. 1970; Am J Clin Pathol, 54: 193-8.
12. Gogia A, Agarwal PK, Khosla P, Jain S, Jain KP. Quinolone resistant typhoid fever. Indian J Med Sci. 2006; 60 (9): 389-90.
13. Srikantiah P, Girgis FY, Luby SP, Jennings G, Wasfy MO, Crump JA, et al. Population based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg. 2006; 74 (1): 114-9.
14. Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration, J Infect Chemother. 2006; 12 (6): 402-4.
15. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug resistant and extended spectrum beta lactamase (ESBL) producing Salmonella enterica (serotypes typhi and paratyphi A) from blood isolates in Nepal: Surveillance of resistance and a search for newer alternatives. Int J Infect Dis. 2006; 10 (6): 434-8.
16. Ray P, Sharma J, Marak RS, Garg RK. Predictive efficacy of nalidixic acid resistance and as marker of fluoroquinolone resistance in Salmonella enterica var typhi. 2006; Indian J Med Res,124 (1): 105-8.
17. Cooke FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of typhoid fever imported into England, Scotland and Wales (2002-2003). Trans R Soc Med Hyg. 2007; 101 (4): 398-404.
18. El-Din SS, Haseeb NM, Hussein MM, Abdel Wahab MF, Helmy AZ, El-Sagheer M. Chloramphenicol drug failure in typhoid fever. J Egypt Public Health Assoc. 1996;71 (1-2): 63-78.
19. Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basic current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi, and paratyphi. Indian. J Med Microbiol. 2006; 24 (21): 101-6.
20. Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid salmonellae in Rawlpindi, Pakistan. East Mediter Health J. 2005;11 (5-6): 1038-44.
21. Abdel Wahab MF, el-Gindy IM, Sultan Y, el-Naby HM. Comparative study on different recent diagnostic and therapeutic regimens in acute typhoid fever. J Egypt Public Health Assoc. 1999; 74 (1-2): 193-205.
22. Abdool Gaffar MS, Seedat YK, Coovadia YM. The white cell count in typhoid fever. Trop Geogr Med. 1992;44(1-2):23-7.
23. James J, Dutta TK, Jayanthi S. Correlation of clinical and hematological profile with bone marrow response in typhoid fever. Am J Trop Med Hyg. 1997;57(3):313-6
24. Hassanein F, Mostafa FM, Elbehairy F, Hammam HM, Allam FA, El-Rehaiwy M, et al. Study of the pattern of Widal test in infants and children; II. Pattern of Widal test in children with enteric fevers. An attempt to define the diagnostic titer for Upper Egypt. Gaz Egypt Paediatr Assoc. 1975;23 (2): 173-80.
25. Frimpong EH, Feglo P, Essel-Ahun M, Addy PA. Determination of diagnostic Widal titers in Kumasi, Ghana. West Afr J Med. 2000;19 (1): 34-8.
26. Dimitrov T, Udo EE, Albaksami O, Al-Shehab S, Kilani A, Shehab M, et al. Clinical and microbiological investigations of typhoid fever in an infectious disease hospital in Kuwait. J Med Microbiol. 2007; 56,538-544.